Gender Differences in Dose of Erythropoietin to Maintain Hemoglobin Target in Hemodialysis Patients

Dialysis patients receiving erythropoietin (EPO) for anemia management are a challenge due to the significant interindividual variability in erythropoietic response. Our objective was to determine if there is a gender-dependent difference in the EPO doses required to maintain the hemoglobin (Hb) tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Coronado Daza, J. A., Cuchi, G. Urrútia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521763/
https://www.ncbi.nlm.nih.gov/pubmed/31142961
http://dx.doi.org/10.4103/ijn.IJN_124_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521763/
https://www.ncbi.nlm.nih.gov/pubmed/31142961
http://dx.doi.org/10.4103/ijn.IJN_124_18

Ejemplares similares